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Abstract 
Expression of the rat insulin II gene is controlled mainly at the level of transcription initiation by multiple factors binding to specific &acting 
DNA-elements in the regulatory region. We have shown that two elements (CT-motifs) located between nucleotides -83 and -76 (CT-l) and -204 
and -197 (CT-2) are involved in transcriptional regulation in the insulin-producing cell line HIT M2.2.2. Transient expression analysis of 5’-deletion 
as well as block replacement mutants revealed that CT-l and CT-2 are mutational sensitive. Gel mobility shift assays showed that both motifs bind 
similar nuclear factors. Gur results suggest the involvement of a third CT-motif located directly upstream of CT-2 on the complementary strand. 
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1. Introduction 
The expression of the insulin gene in adult organisms 
is restricted to pancreatic jkells which are therefore a 
useful model system to study cell-specific expression. 
In rats and mice, there are two equally expressed, 
non-allelic insulin genes (I and II) which differ both in 
their exon-intron structure and in their chromosomal 
location [l]. Additionally, there are differences in the 
mechanisms acting to control their enhancer-driven ex- 
pression (reviewed in [2]). 
A highly conserved DNA element present in two cop- 
ies in the rat insulin I gene (-241 to -233 and -112 to 
-104) and in one copy in the rat insulin II gene (-100 
to -91) [3-51 plays a predominant role in cell specific 
expression . This element, referred to as ‘Insulin Control 
Element’ (ICE), has been found in all characterised insu- 
lin genes [ 11. It contains the core motif CANNTG which 
is the binding site motif for proteins in the basic helix- 
loop-helix (B-HLH) family [6]. 
Enhancer-stimulated expression is regulated by the 
combined actions of the ICE with other c&acting tran- 
scriptional regulators. The reported mini-enhancer re- 
gions differ greatly and lie between nucleotides -247 and 
-197 in the rat insulin I gene (Far-FLAT-element (FF) 
[7]) and -126 and -86 in the rat insulin II gene (Rat 
Insulin II Promoter Element 3 (RIPE3) [8]). The ICE is 
the only conserved element present within each of these 
mini-enhancers. 
It has been shown for the human insulin gene that a 
factor (IUF-1) present in jkells but not in a-cells binds 
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to the consensus sequence PyCTAATG (termed CT-box) 
at positions -77 (CT-l-box), -210 (CT-2-box) and -313 
(CT-3-box) [9]. The rat insulin I gene as well as the rat 
insulin II gene contain at least two CT-boxes in their 
5’-regions. The core sequences CTAAT and CTTAAT 
and the distance between CT-1 and CT-2 are highly con- 
served among species (Fig. 1). CT-boxes are also in- 
volved in the cell-specifk control of the glucokinase gene 
in jl cells [lo]. 
Considering these data, and because a CT-box is part 
of the FF-mini-enhancer of the rat insulin I [7] gene but 
not of the rat insulin II gene-associated RIPE3 mini- 
enhancer [8], we investigated the role of CT-boxes in the 
rat insulin II gene. In this paper we demonstrate that 
CT-boxes are important for the expression of the rat 
insulin II gene. 
2. Materials and methods 
2.1. Plasmids and construction of CAT expression vectors 
A DNA fragment containing 884 bp of the S’danking region and 129 
bp of the first exon of the rat insulin II gene was amplified by PCR from 
genomic DNA (Wistar rat). The resulting fragment was subcloned into 
pBluescript KS’ (Stratagene) to generate the plasmid pBSRINSI1, 
which served as the starting material for most of the constructs de- 
scribed. Deletions at the S’end of the insert were generated using either 
restriction enzymes or Baa1 nuclease digestion. Stepwise shortened 
fragments were subcloned into the promoterless expression vector 
pBSVOCAT [11] to yield the expression constructs pBRINSII-n/ 
+129CAT. pBTKCAT [11] contains the HSV thymidine kinase pro- 
moter (-109/+56). 
2.2. Systematic mutagenesis 
The block replacement mutants were constructed using the Muta- 
Gene In Vitro Mutagenesis Kit from BioRad Laboratories. The ol- 
igonucleotide-directed in vitro mutagenesis is based on the method of 
Kunkel [12]. Mutagenesis was performed directly on the expression 
vector pBRINSII-278CAT using the fl-origin of replication carried by 
the pBluescript vector for single-strand DNA preparation. Most mu- 
tants contained a block of noncomplementary transversion mutations 
(A/C;GfI’). 
All rights reserved. 
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2.3. Oligonucleotides 
Deoxyoligonucleotides were synthesised by Dr. P. Gppermann, 
Greifswald, Germany. Single-stranded oligonucleotides were purified 
by polyacrylamide gel electrophoresis. Sequences of nucleotides used 
are: 
(ICE-like a) 5’-CTGGTTCATCAGGCCACCCAGGAGCCCCTAT- 
TAAGACTC-3, (b) 5’-GAGTCMAATAGGGGCTCCTGGGTGG- 
CCTGATGAACCAG-3’; (CT-2 a) 5’-GAGCCCCTATTAAGACTC- 
TAAT-IACCCTAAGGCTAAG-3’, (b) 5’-CTIAGCCTTAGGGTA- 
AI-TAGAGTCTTAATAGGGGC TC-3’; (CT-l a) 5’-CATCTGCTG- 
ATCCACCCITAATGGGACAAACACAAAG-3, (b) 5’-Cl-fTGC- 
TG’ITTGTCCCATTAAGGGTGGATCAGCAGATG-3’; (ICE a) 5’- 
AGCTTCAGCCCCTCTGGCCATCTGCTGATCCACCCTTAA-3’, 
(b) 5’-TTAAGGGTGGATCAGCAGATGGCCAGAGGGGCTGA- 
AGCT-3’; 
Sequences ‘a’ represent the upper strands, and ‘b’ the lower strands 
of the oligonucleotides used, respectively. 
2.4. Ohgonucleotide labelling 
Double-stranded oligonucleotides for EMSA were end-labelled using 
40 pmol DNA, 60 &i [$*P]ATP, and 10 units of T4 polynucleotide 
kinase as described [13]. Oligonucleotides were purified by nondenatur- 
ing polyacrylamide gel electrophoresis followed by Sephadex G50 
chromatography. 
2.5. Preparation of nuclear extracts 
Crude nuclear extracts were prepared from established cell lines as 
described [14,15]. After precipitating with ammonium sulphate (0.33 
g/ml) nuclear proteins were redissolved in 20 mM HEPES-KOH (pH 
7.9), 25% (v/v) glycerol, 50 mM KCI, 1.5 mM MgC&, 0.5 mM PMSF, 
0.5 mM s-aminocapronic acid, and 2.5 &ml Trasylol. Dialysis was 
performed at 4°C against 500 volumes of this buffer with three butfer 
changes for 2 h each. The extracts were subsequently centrifuged for 
10 min at 15,000 x g at 4°C and aliquots of the resulting supernatant 
were quick frozen on dry ice and stored at -80°C until use. Protein 
concentration was estimated according to Bradford [16] and varied 
from 5-10 mg/ml. 
2.6, Electrophoretic mobility shift assay (EMSA) 
lO-15pg of nuclear extracts were incubated with 10-50 fmol labelled 
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double-stranded oligonucleotides (10,000 cpm per incubation) and 1.5 
pug poly(dIdC)(dIdC) in 50 mM KCl, 15% (v/v) glycerol, 1 mM dithio- 
threitol, 50 mM NaCl, for 30 min at 22°C. The incubation mixtures 
were run on a water-cooled 6% (w/v) native polyacrylamide gel (19 : I, 
acrylamide/Bis-acrylamide) in 50 mM Tris, 50 mM boric acid, 1 mM 
EDTA at 20 mA. Following electrophoresis the gel was transferred 
dried and exposed to X-ray film. 
Competition assays were performed as described above except that 
the nuclear extracts were preincubated with unlabelled competitor 
probes (5&100-fold molar excess) for 15 min at 22°C. The high amount 
of poly(dIdC)(dIdC) was included to minimise unspecific aggregation 
of DNA-protein complexes. 
2.7 CeN lines 
The insulin-producing cell line HIT M2.2.2 was grown in RPM1 
1640. Hamster kidney fibroblast cells, BHK21, were grown in Glasgow 
modification of Eagles medium. All growth media were supplemented 
with 40 units/ml penicillin, 40 &ml streptomycin, 2 mM glutamine, 
and 10% foetal calf serum. Endogenous synthesis of insulin by HIT 
M2.2.2 was monitored by standard insulin RIA. 
2.8. Transfections and CAT assays 
Transfection of HIT M2.2.2 and BHK21 cells was performed by the 
calcium phosphate co-precipitation technique [17J, using 10 pug CsCl- 
purified CAT expression vectors and 4 fig pRSVSga1 per 100 mm dish. 
Transfections were carried out in Dulbecco’s modified Eagles medium 
containing 2 g/l glucose supplemented as above. Cells were harvested 
and protein extracts prepared 40-48 h after transfection. Extracts were 
analysed for CAT and B-gal activities [18]. CAT enzyme activity was 
normal&d against p-galactosidase (J-gal) activity obtained from the 
co-transfected control plasmid. 
3. Results 
3. I. Transient expression of 5’-deletion mutants 
The CAT activities obtained after transfection of 
5-deletion mutants in HIT M2.2.2 and BHK21 cells are 
(Far) (FLAT - E/FLAT - F) (Nir) 
5--flanking region and structure of the rat insulin II gone 
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Location of highly conseme dcT-boxesofinsulin~csofdiffercntspedm 
human: -217 CTCTAATG -210 -84 CCCTAATG -77 
dog: -173 CTCTAACG -166 -59 CCCTCATG -52 
mouse: -216 CTATAATA -209 -83 CCITAATG -76 
rins I: -216 ATCTAA’IT -209 -83 CCIT&YI-G -76 
rlns II: -204 Cl-CT&WI- -197 -83 CCITAATG -76 
Fig. I. Structure of the rat insulin I and II gene transcriptional units and the position and sequence of CT-boxes of different insulin genes. cis-Elements 
are boxed and the 5’-end shown above the box. The sequences of the CT-boxes are shown below. Dark boxes represent introns. 
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shown in Fig. 2. Maximal activity in HIT M2.2.2 cells 
was achieved with the -218 mutant. Shortening to -192, 
which deletes the CT-Zbox but leaves the entire RIPE3 
element untouched, led to a decrease in activity of nearly 
80%. Compared to the -218 mutant the activity de- 
creased about 40-fold in the -99 mutant, which lacks the 
proper RIPE3 but still contains the ICE and CT-l-box. 
Less than maximal activity was obtained with the -238 
construct which harbours additionally an ICE-like se- 
quence (CANNAG) or with longer constructs (up to 
-884; data not shown). 
Independent of the length of the promoter, all con- 
structs were expressed only weakly after transfection into 
BHK21 cells. 
3.2. Transient expression of block replacement mutants 
To prove the importance of the ICE- and CT-boxes in 
transcriptional control of pBRINSII-278CAT, the se- 
quences of these motifs were replaced by block muta- 
tions. The block replacement mutants as well as the re- 
sulting CAT activities obtained in transient expression 
assays are seen in Fig. 3. The most dramatic effect was 
observed with the mutant M7. Destruction of the ICE- 
motif almost completely abolished CAT expression. The 
CT- 1 -box is very sensitive to mutation (M4) reducing the 
CAT activity to 33% of the wild type control. Changing 
the CT-Zbox (M2;M3) led also to a decrease in CAT 
activity (about 60% of the control). The results obtained 
with M5 demonstrate that CT-l can in part be function- 
ally replaced by CT-2. Using M6, containing a mutated 
ICE-like motif, a CAT activity of only 43% of the wild 
type was measured. Interesting results were also ob- 
tained with M 1. This mutation generates a Far-FLAT-E- 
motif similar to the rat insulin I mini-enhancer and led 
to an increase in activity to nearly 130%. Last but not 
least these experiments show that the CAAT-box (M8) 
also is mutationally sensitive. 
No mutation showed an increase of expression in the 
non-insulin producing cell line BHK indicating that no 
single motif is responsible for the repression of the /?-cell 
specific promoter in that cell type. 
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3.3. Electrophoretic mobility shift analyses 
To characterise the trans-acting factors that bind to the 
investigated motifs, nuclear extracts of HIT M2.2.2 cells 
were used in electrophoretic mobility shift assays 
(EMSAs). The results are shown in Fig. 4. In Fig. 4A-D 
are shown complexes formed with oligonucleotides con- 
taining in their central positions the motifs CT-2, CT-l, 
ICE-like, and ICE, respectively. To verify the specificity 
of binding and to evaluate possible interactions between 
different cis-acting elements, binding reactions were con- 
ducted in the presence of lOO-fold molar excess of unla- 
belled oligonucleotides as indicated at the top of each 
lane. In each case the first lane shows the binding pattern 
without competitor. 
Using oligonucleotide CT-2 three retarded complexes 
(a,b,c) were observed (Fig. 4A, lane l), whereas oligonu- 
cleotide CT-l formed only two (b,c) retarded complexes 
(Fig. 4B, lane 1). 
The presence of excess unlabelled oligonucleotides, ei- 
ther CT-1 or CT-2, respectively, abolished the formation 
of the bands ‘b’ and ‘c’ indicating that both motifs bind 
similar nuclear factors (Fig. 4A, lane 2; Fig. 4B, lane 3). 
Self-competition using lOO-fold molar excess of the same 
but unlabelled oligonucleotide, abolished binding of nu- 
clear factors (data not shown). Excess oligonucleotides 
with the ICE-motif showed no competition whereas ol- 
igonucleotides with the ICE-like motif competed weakly 
for complex formation with CT-2 (Fig. 4A, lane 4) and 
in a stronger manner with CT-1 (not shown). An ol- 
igonucleotide containing a mutated CT-1 motif, i.e. 
mCT-1, identical to M4 (Fig. 3), was not able to compete 
for binding with CT-l (not shown). 
Several complexes are formed with oligonucleotides 
containing the ICE or ICE-like motif (Fig. 4C and 4D). 
Competition assays showed that similar proteins bind 
probably to both motifs, forming the complexes d, e, f, 
and i, j, k, respectively. However, although an excess of 
ICE was able to abolish the complexes d,e, and f formed 
by the ICE-like oligonucleotide, the ICE-like sequence 
could not compete for ICE complexes (Fig. 4C, lane 2; 
Fig. 4D, lane 4). This strongly indicates that the two 
14. CAT-activity In 96 
Fig. 2. Transient expression of CAT activity by the rat insulin II gene promoter deletion mutants in HIT M2.2.2 (hatched boxes) and BHK21 cells 
(dark boxes). Mutants were generated and cells were transfected as described in section 2. CAT activities were normal&d to/?-gal activities. Values 
represent averages of at least three individual experiments and are expressed as percentages of the activities obtained with pTKCAT. 
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-222 -204 
WT 5’ *CE-like- 
axGG4G CTCTAAT 
rd. CAT-activity in % -165 
-98 -83 
1-1 
-30 
m I ICE 100 
CCAATT CCATCTG CClTAATG TATAAA 
Ml s-l Ict B I WAT TATA -I 129 
CCATCTG 
~2 5.-)CE-like- 
CGCAACT 
ICPAT, CT-l TATA ’ 61.3 
M6 5,u 43 
AACGAGT 
M7 s-1 m ICE-like CT- 
AACGAGT 
M6 5.*CE-like 1 CT-1 TATA ’ 
AACCGG 
M6 5’ ICE-like -j-m ICAAT,,,, 1’f 
AWXXXGT- AACGAGT --I. 
Fig. 3. Transient expression of CAT activity of block replacement mutants of the pBRINSII-278/+129CAT construct in HIT M2.2.2 (hatched 
columns) and BHK21 cells (dark columns). CAT activities are corrected for transfer efficiency using the/Lgalactosidase activity and represent averages 
of at least three individual experiments and are expressed as percentages of the activity obtained with the wild type control (WT). Sequences of the 
block mutants are shown (black boxes). 
motifs differ greatly in binding affinity for the common CT-boxes bind similar, probably identical, nuclear fac- 
factors, or factors unique to one or both motifs are also tors (Fig. 4A,B, bands b,c). Proteins generating complex 
involved in complex formation. The complex ‘g’ is ‘b’ bind with higher affinity to CT-1 in comparison to 
formed only with the ICE-like motif and disappeared in CT-2. This and the ability to bind further proteins (Fig. 
the presence of excess CT-l (Fig. 4C) confirming the 4A, complex ‘a’) may be the reason that CT-2 can only 
results already observed in competition studies using la- in part functionally replace CT-1 in CAT-expression 
belled oligonucleotides containing CT motifs. studies (Fig. 3, M5). 
4. Discussion 
Although known to be very important for cell specific 
expression of the human insulin gene [9] and of the rat 
insulin I gene [7] and located in a highly conserved form 
in nearly the same position (Fig. 1) the CT-boxes of the 
rat insulin gene II have been neglected so far. Here we 
demonstrate that CT-boxes are c&elements involved in 
the transcriptional control of the rat insulin II gene in the 
insulin producing cell line HIT M2.2.2. Removing the 
distal CT-box by 5’-deletion led to a decrease in the 
promoter driven CAT activity. CAT expression is af- 
fected by mutation of either CT-box, and especially the 
mutated CT- 1 -motif greatly influenced CAT activity. 
The core motifs of CT-l and CT-2 are very similar (Fig. 
l), and it can be concluded from EMSA studies that both 
Furthermore, our studies confirmed that the ICE 
motif plays a crucial role in expression of the rat insulin 
II gene in HIT cells, as was also reported for the /I-cell 
derived PC-1 [19]. Although this motif seems to be 
necessary (Fig. 3, M7) it is not sufficient to direct en- 
hanced cell specific expression (Fig. 2). The involvement 
of further cis-ltrans-acting factors is required for en- 
hanced expression. In this regard it has been reported 
that two further factors specific for /3-cells are binding 
between - 115 and -99, and act in concert with the ICE 
binding complex to stimulate transcription [8]. Our stud- 
ies indicate that additionally the CT motifs are modulat- 
ing transcriptional activity of the promoter. Further- 
more, we have shown that these motifs are also involved 
in transcriptional control of the B-cell specific promoter 
of the rat glucokinase gene [10,20] and that CT motifs of 
different genes expressed in B-cell derived cell lines bind 
similar nuclear factors [20]. 
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a+ 
b- 
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d- 
e.f X 
- I ICE I CT-1 
-ICE-llke - 
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Fig. 4. Binding of HIT M2.2.2 nuclear extract to 30-bp oligonucleotides containing the CT-2 (A), CT-l (B), ICE-lie (C), and ICE (D) motifs of 
the rat insulin II gene in central position. The binding specificities of HIT nuclear proteins were tested by EMSA using an lOO-fold excess of unlabelled 
competitors indicated at the top of each lane. 
b- 
B lane 1 2 3 
Competitors : - I CT-l /CT-2 / ICE-I. 
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Besides the demonstration of the participation of the 
ICE as well as the CT-1 and CT-2 motifs in transcrip- 
tional control of the rat insulin II gene in HIT M2.2.2 
cells, the ICE-like motif located upstream also seems to 
be involved. This motif is mutationally sensitive (Fig. 3, 
M6), but the presence of the ICE-like motif did not en- 
hance transcription in the transient expression studies of 
deletion mutants. It has been shown that the ICE motif 
is the target for both positive and negative regulation of 
insulin gene transcription [8,19,21,22]. This may also be 
true for the ICE-like motif. 
In a comparison of the DNA-sequence of the 5'-flank- 
ing region of the rat insulin II gene isolated by us from 
genomic DNA of Wistar rats to the previously published 
sequence (GenBank, Accession No. J00748) we observed 
a difference at position -211, where a G is replaced by 
T. This change leads to a new CT-motif on the comple- 
mentary strand, directly upstream of the CT-2 motif. 
This explains well the observed competition behaviour 
of the 'ICE-like oligonucleotide' with respect to CT-1, 
because it contains the new CT-motif. Work is in pro- 
gress to analyse whether this sequence is restricted to 
Wistar rats. 
The Far-FLAT-box, containing an ICE-similar as well 
as a CT-motif, acts as a mini-enhancer in the rat insulin 
I gene. The respective region in the rat insulin II gene is 
not well conserved and has no true enhancer properties 
[7]. A similar combination of ICE and CT motifs is lo- 
cated further downstream in both rat insulin genes (Fig. 
1). To characterise protein binding to these motifs, we 
used a 50-bp oligonucleotide containing both the ICE 
and the CT-1 motif. Most surprisingly, the presence of 
both motifs in combination did not lead to the formation 
of new retarded complexes of lower mobility different 
from retarded complexes formed by either ICE or CT-1 
alone (not shown). We suggest that the trans-acting fac- 
tors binding to CT-1 and ICE cis-acting elements seem 
to recognise the sequence motifs separately and bind not 
simultaneously (manuscript in preparation). 
The presented data demonstrate that besides the well 
described RIPE3/ICE region additionally CT-motifs are 
involved in transcriptional regulation of the rat insulin 
II gene in insulin-producing cells. It becomes more obvi- 
ous that initiation of transcription is a process of high 
complexity requiring co-ordinated binding of multiple 
factors probably in a certair~, sequence. 
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